Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism

por Brod, Meryl, Waldman, Laura Tesler, Shu, Aimee D., Smith, Alden
Publicado 2023

Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency

por Lin, Zhengning, Shu, Aimee D, Bach, Mark, Miller, Bradley S, Rogol, Alan D
Publicado 2021

THU164 Design Of The New InsiGHTS Trial: A Multicenter, Phase 2, Randomized, Open-label, Active Controlled Study To Investigate The Safety, Tolerability, And Efficacy Of Lonapegsom...

por Klein, Karen O, Backeljauw, Philippe, Abdelrahman, Sohair, Lai, Pamela, Mao, Meng, Shu, Aimee
Publicado 2023

Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES)

por Brod, Meryl, McLeod, Lori, Markova, Denka, Gianettoni, Jill, Mourya, Sanchita, Lin, Zhengning, Shu, Aimee, Smith, Alden
Publicado 2021

Declining Rates of Inpatient Parathyroidectomy for Primary Hyperparathyroidism in the US

por Kim, Sun Moon, Shu, Aimee D., Long, Jin, Montez-Rath, Maria E., Leonard, Mary B., Norton, Jeffrey A., Chertow, Glenn M.
Publicado 2016

Design of the ForesiGHt Trial: A Multicenter, Randomized, Placebo- and Active-Controlled Trial to Compare Once-Weekly TransCon hGH (lonapegsomatropin) to Placebo and Daily Somatrop...

por Fleseriu, Maria, Jorgensen, Jens Otto, Yuen, Kevin C J, Hoybye, Charlotte, Mao, Meng, Kang, Jennifer, Song, Wenjie, Komirenko, Allison, Shu, Aimee D, Beckert, Michael
Publicado 2021

OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial

por Thornton, Paul, Hofman, Paul, Maniatis, Aristides, Aghajanova, Elena, Chertok, Elena, Korpal-Szczyrska, Maria, Giorgadze, Elene, Kovalenko, Tatiana, Shu, Aimee, Karpf, David, Beckert, Michael, Leff, Jonathan
Publicado 2019

THU173 Subanalysis By Tanner Stage In Phase 3 Trials In Children And Adolescents With Growth Hormone Deficiency Treated With Lonapegsomatropin

por Hofman, Paul, Thornton, Paul S, Nadgir, Ulhas M, Saenger, Paul, Chertok, Elena, Aghajanova, Elena M, Mao, Meng, Zhao, Carol, Ochoa-Maya, Margarita R, Komirenko, Allison, Shu, Aimee D, Maniatis, Aristides K
Publicado 2023

Efficacy and Safety of up to 2 Years of Treatment With TransCon hGH (Lonapegsomatropin) in Treatment-Naïve and Treatment-Experienced Children With Growth Hormone Deficiency

por Maniatis, Aristides K, Casella, Samuel J, Nadgir, Ulhas M, Hofman, Paul, Saenger, Paul, Chertok, Elena, Aghajanova, Elena M, Song, Wenjie, Mao, Meng, Chessler, Steven D, Komirenko, Allison, Beckert, Michael, Shu, Aimee D, Thornton, Paul S
Publicado 2021

OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism

por Ahmed, Intekhab, Eriksen, Erik, Hofbauer, Lorenz, Khan, Aliya, Le, John, Marcocci, Claudio, Markova, Denka, Pagotto, Uberto, Palermo, Andrea, Pihl, Susanne, Rejnmark, Lars, Schwarz, Peter, Shu, Aimee, Sibley, Christopher, Vansaghi, Lisa, Vokes, Tamara, Clarke, Bart
Publicado 2022

Response to Letter to the Editor From Malozowski: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”

por Thornton, Paul S, Maniatis, Aristides K, Aghajanova, Elena, Chertok, Elena, Lin, Zhengning, Song, Wenjie, Christoffersen, Eva Dam, Breinholt, Vibeke Miller, Giorgadze, Elene, Korpal-Szczyrska, Maria, Hofman, Paul L, Karpf, David B, Shu, Aimee D, Beckert, Michael
Publicado 2021

Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial

por Maniatis, Aristides K., Nadgir, Ulhas, Saenger, Paul, Reifschneider, Kent L., Abuzzahab, Jennifer, Deeb, Larry, Fox, Larry A., Woods, Katie A., Song, Wenjie, Mao, Meng, Chessler, Steven D., Komirenko, Allison S., Shu, Aimee D., Casella, Samuel J., Thornton, Paul S.
Publicado 2022

SAT-LB16 Maintenance of Favorable Treatment Effect of Once-Weekly TransCon hGH for Children With Growth Hormone Deficiency: Interim Analysis From the Enlighten Long-Term Extension...

por Maniatis, Aristides K, Casella, Samuel J, Nadgir, Ulhas M, Mick, Gail J, Hofman, Paul, Saenger, Paul, Chertok, Elena D, Warshauer, Jeremy, Song, Wenjie, Peng, Jessica M, Komirenko, Allison S, Shu, Aimee D, Beckert, Michael, Aghajanova, Elena M, Thornton, Paul S
Publicado 2020

TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension

por Rubin, Mishaela R, Rejnmark, Lars, Schwarz, Peter E, Vokes, Tamara J, Clarke, Bart, Ahmed, Intekhab, Hofbauer, Lorenz C, Palermo, Andrea, Marcocci, Claudio, Pagotto, Uberto, Eriksen, Erik F, Mourya, Sanchita, Markova, Denka, Pihl, Susanne, Shu, Aimee D, Khan, Aliya
Publicado 2021

OR10-05 Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency

por Maniatis, Aristides K, Nadgir, Ulhas, Saenger, Paul, Mick, Gail, Reifschneider, Kent L, Abuzzahab, Mary Jennifer, Deeb, Larry, Fox, Larry A, Woods, Katie A, Peng, Jessica M, Karpf, David B, Shu, Aimee D, Song, Wenjie, Casella, Samuel J, Thornton, Paul S
Publicado 2020

Weekly Lonapegsomatropin in Treatment–Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial

por Thornton, Paul S, Maniatis, Aristides K, Aghajanova, Elena, Chertok, Elena, Vlachopapadopoulou, Elpis, Lin, Zhengning, Song, Wenjie, Christoffersen, Eva Dam, Breinholt, Vibeke Miller, Kovalenko, Tatiana, Giorgadze, Elene, Korpal-Szczyrska, Maria, Hofman, Paul L, Karpf, David B, Shu, Aimee D, Beckert, Michael
Publicado 2021

Response to Letter to the Editor From L. Sävendahl et al: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”

por Thornton, Paul S, Maniatis, Aristides K, Aghajanova, Elena, Chertok, Elena, Vlachopapadopoulou, Elpis, Lin, Zhengning, Song, Wenjie, Christoffersen, Eva Dam, Breinholt, Vibeke Miller, Kovalenko, Tatiana, Giorgadze, Elene, Korpal-Szczyrska, Maria, Hofman, Paul L, Karpf, David B, Shu, Aimee D, Beckert, Michael
Publicado 2021

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

por Khan, Aliya A, Rejnmark, Lars, Rubin, Mishaela, Schwarz, Peter, Vokes, Tamara, Clarke, Bart, Ahmed, Intekhab, Hofbauer, Lorenz, Marcocci, Claudio, Pagotto, Uberto, Palermo, Andrea, Eriksen, Erik, Brod, Meryl, Markova, Denka, Smith, Alden, Pihl, Susanne, Mourya, Sanchita, Karpf, David B, Shu, Aimee D
Publicado 2021

RF26 | PMON332 Safety and Efficacy of Treatment with Lonapegsomatropin in Children with Growth Hormone Deficiency at Week 130 in the enliGHten Trial

por Saenger, Paul, Nadgir, Ulhas, Hofman, Paul, Thornton, Paul, Chertok, Elena D, Aghajanova, Elena M, Korpal-Szczyrska, Maria, Vlachopapadopoulou, Elpis, Malievskiy, Oleg, Chaychenko, Tetyana, Cappa, Marco, Song, Wenjie, Mao, Meng, Chessler, Steven D, Komirenko, Allison S, Beckert, Michael, Shu, Aimee D, Maniatis, Aristides K
Publicado 2022

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial

por Khan, Aliya A, Rubin, Mishaela R, Schwarz, Peter, Vokes, Tamara, Shoback, Dolores M, Gagnon, Claudia, Palermo, Andrea, Marcocci, Claudio, Clarke, Bart L, Abbott, Lisa G, Hofbauer, Lorenz C, Kohlmeier, Lynn, Pihl, Susanne, An, Xuebei, Eng, Walter Frank, Smith, Alden R, Ukena, Jenny, Sibley, Christopher T, Shu, Aimee D, Rejnmark, Lars
Publicado 2022